Results 111 to 120 of about 29,843 (237)

A STUDY OF PNEUMOCOCCUS CARRIERS [PDF]

open access: yesArchives of Internal Medicine, 1919
During the winter of 1917-1918, 1,311 cases of pneumonia were treated at the Base Hospital, Camp Wheeler, Ga., with 275 deaths, constituting the largest mortality of any single disease in the camp, indeed, more than 80 per cent. of all the deaths that occurred.
openaire   +2 more sources

Antimicrobial Resistance in Children With Bloodstream Infections: A Population‐Based Study in Stockholm, Sweden

open access: yesActa Paediatrica, Volume 115, Issue 12, Page 2781-2789, December 2026.
ABSTRACT Aim We retrospectively evaluated trends in antimicrobial resistance (AMR) in paediatric bloodstream infections and assessed changes in antimicrobial prescription patterns over a 20‐year period. Methods We analysed positive blood cultures from children admitted with suspected serious infection between 1998 and 2018.
Joachim Luthander   +5 more
wiley   +1 more source

Exploiting novel Acinetobacter Oligosaccharyltransferases for the development of glycoconjugate vaccines against the Pneumococcus [PDF]

open access: yes, 2016
Vaccines bring many diseases under control, an example of which is the Streptococcus pneumoniae, or the Pneumococcus. Pneumococcus is one of the leading causes of meningitis in children under 5 years, and is responsible for almost a million child deaths ...
Nasr, Mohamed A.
core   +1 more source

IMMUNIZATION IN PNEUMOCOCCUS INFECTIONS [PDF]

open access: yesJournal of the American Medical Association, 1912
The formation of antibodies in those infections due to bacteria which produce little or no soluble toxins is held to be due to the stimulus of the whole bacterium in question. Intoxication and immunization are held to be due to the same cause. The idea that there are produced during infections substances purely toxic in nature which do not call forth ...
openaire   +2 more sources

Data and R codes associated with the paper "Unraveling the seasonal epidemiology of pneumococcus"

open access: yes, 2019
The zipped folder contains the data and the R codes needed to perform the estimation of the models described in Domenech de Cellès et al., "Unraveling the seasonal epidemiology of pneumococcus ...
Didier Guillemot (69521)   +15 more
core   +1 more source

Cancer co‐medication quality in older patients with polypharmacy: A large randomized trial testing a medication review versus usual care

open access: yesJournal of Internal Medicine, Volume 300, Issue 6, Page 802-820, December 2026.
Abstract Background Evidence from randomized controlled trials (RCTs) testing medication reviews in geriatric oncology is sparse. Methods We conducted a single‐blinded RCT in ten rehabilitation clinics across Germany. Patients with common cancers, aged ≥ 65 years, and polypharmacy (regularly ≥ five drugs) were randomly allocated in equal proportions to
Miriam Degen   +15 more
wiley   +1 more source

Pneumococcus, Pneumococcal Disease, and Prevention.

open access: yes, 2016
First isolated in 1880 by Pasteur in the saliva of a patient with rabies, Strep-tococcus pneumoniae (also known as the pneumococcus) has been branded asthe “captain of the men of death” by William Osler, for the nefarious role thisorganism plays in ...
Malley, Richard   +3 more
core  

Bispecific antibodies targeting B‐cell maturation antigen in multiple myeloma: Current clinical applications, challenges and future directions

open access: yesCancer, Volume 132, Issue 22, 15 November 2026.
Abstract Anti‐B cell maturation antigen (BCMA) therapies, including antibody‐drug conjugates, chimeric antigen receptor T cells, and bispecific antibodies (bsAbs), have recently revolutionized the treatment landscape of multiple myeloma. This review outlines the biologic rationale for targeting BCMA and sheds light on the mechanism of action of bsAbs ...
Enrica Manzato   +5 more
wiley   +1 more source

STUDIES ON THE PNEUMOCOCCUS [PDF]

open access: yesJournal of Experimental Medicine, 1905
C W, Duval, P A, Lewis
openaire   +2 more sources

Targeting the NR1D1–IGF2BP2–V‐ATPase Axis With Hybrid Nanovesicles Restores Macrophage Rhythms to Reverse Sepsis‐Induced Immunosuppression

open access: yesAdvanced Science, Volume 13, Issue 62, 9 November 2026.
Sepsis disrupts immune‐cell rhythms and weakens bacterial clearance. Biomimetic nanovesicles combining erythrocyte and inflammation‐activated macrophage membranes deliver siNR1D1 to dysfunctional macrophages, restoring the NR1D1–IGF2BP2–V‐ATPase pathway, circadian regulation, phagolysosomal acidification, and antimicrobial defense.
Lang Chen   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy